Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Splice Therapeutics
Barcelona, Catalonia, Spainsplice.bio ↗
- Ownership
- Private
- Employees
- ~30
- Development stage
- Other
01
Overview
SpliceBio is a biotechnology company based in Barcelona that specializes in developing next-generation gene therapies to treat genetic diseases. The company's proprietary Protein Splicing platform utilizes engineered inteins to overcome the cargo capacity limitations of Adeno-Associated Virus (AAV) vectors, enabling the delivery of large genes. Their lead program, SB007, targets Stargardt disease, a common form of inherited macular degeneration caused by mutations in the large ABCA4 gene. By reconstituting full-length proteins from two separate AAV vectors, SpliceBio aims to address previously undruggable genetic conditions. The company is backed by a strong syndicate of international life science investors and is expanding its pipeline into other therapeutic areas.
- Therapeutic areas
- Ophthalmology
- Modalities
- Gene therapyAAV vector
- Industry
- Biotech
Beyond the preview
Go deeper on Splice Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Splice Therapeutics.